Search clinical trials for: metastatic or unresectable melanoma
Total 211899 results
-
Bristol-Myers SquibbCompletedAdvanced Cutaneous MelanomaGermany, Poland, Spain, Australia, France, Argentina, Ireland, Israel, Belgium, United States, Switzerland, United Kingdom, Greece, Austria, Canada
-
CytomX TherapeuticsTerminatedSolid Tumor | Unresectable or Metastatic MelanomaKorea, Republic of, United States, Netherlands, Spain, Australia
-
Pierre Fabre MedicamentBiotrialActive, not recruitingMelanoma | Metastatic Melanoma | Unresectable Melanoma | BRAF V600 MutationFrance
-
Delcath Systems Inc.National Cancer Institute (NCI)CompletedMetastatic Cancer | Intraocular Melanoma | Melanoma (Skin)United States
-
Ultimovacs ASAOslo University HospitalActive, not recruiting
-
PfizerCompletedMetastatic or Unresectable Cutaneous MelanomaUnited States, Spain, Canada, Italy, United Kingdom, Germany, Korea, Republic of, France, Australia, Czechia, Russian Federation, Turkey, Israel, Netherlands, Greece, Hungary, Japan, Portugal, Argentina, Austria, Belgium, Brazil, Po... and more
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, United Kingdom, Austria, Belgium, Hungary, Canada, Netherlands, Argentina, Australia, Brazil, Czechia, Denmark, France, Germany, Israel, Italy, Norway, Poland, Russian Federation, Spain, Switzerland, Taiwan, Korea, Republic... and more
-
Prof. Dr. med. Dirk SchadendorfCompleted
-
Cambridge University Hospitals NHS Foundation TrustUniversity of Oxford; National Institute for Health Research, United Kingdom; Oxford University Hospitals NHS TrustCompleted
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedMelanomaUnited States, France, Italy, United Kingdom, Spain, Belgium, Israel, Mexico, Japan, Canada, Netherlands, Sweden, Korea, Republic of, Australia, Russian Federation, Chile, Germany, Poland, Ireland, New Zealand, Denmark, Switzerland, South Africa
-
Daiichi Sankyo, Inc.PlexxikonTerminatedV600-mutated BRAF Unresectable Melanoma | V600-mutated BRAF Metastatic Melanoma | Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF InhibitorUnited States, Germany, France
-
Hospices Civils de LyonUnknownMetastatic NRAS MelanomaFrance
-
Takara Bio Inc.CompletedMelanoma Stage IV | Melanoma Stage IIIJapan
-
Grupo Español Multidisciplinar de MelanomaRoche Farma, S.A; Pivotal S.L.Completed
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedMetastatic Melanoma | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Unresectable Melanoma | Mucosal Melanoma | Stage IV Uveal Melanoma AJCC v7United States
-
Immutep Australia Pty. Ltd.CompletedStage IV Melanoma | Stage III MelanomaAustralia
-
University Health Network, TorontoCompletedMetastatic, Stage III or Stage IV, MelanomaCanada
-
GlaxoSmithKlineCompletedMelanomaFrance, Italy, Germany, Netherlands, Switzerland, United Kingdom, Austria, Australia
-
Celldex TherapeuticsTerminated
-
Leap Therapeutics, Inc.Cancer Research Institute, New York CityCompletedUnresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor MalignanciesUnited States
-
Hoffmann-La RocheCompleted
-
MedImmune LLCCompletedMelanomaItaly, United States, Canada, France
-
BiocadCompletedMelanomaRussian Federation
-
Incyte CorporationTerminated
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Uveal Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Iris Melanoma | Recurrent Intraocular Melanoma | Extraocular Extension MelanomaCanada, United States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Terminated
-
Takara Bio Inc.TheradexCompletedMalignant MelanomaUnited States
-
Immodulon Therapeutics LtdTerminatedMetastatic CancerFrance, United Kingdom
-
Hoffmann-La RocheCompletedMalignant MelanomaItaly, United Kingdom, Belgium, Poland, Netherlands, Germany, Austria, Czechia, Ireland, Sweden
-
University of Texas Southwestern Medical CenterCompleted
-
GlaxoSmithKlineCompleted
-
AHS Cancer Control AlbertaCompleted
-
Immune DesignCompletedMelanoma | Sarcoma | Breast Cancer | Ovarian Cancer | Non-small Cell Lung CancerUnited States
-
GlaxoSmithKlineNo longer available
-
Beth Israel Deaconess Medical CenterNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterBristol-Myers SquibbTerminated
-
Genentech, Inc.Terminated
-
Dana-Farber Cancer InstituteSynta Pharmaceuticals Corp.TerminatedMelanomaUnited States
-
California Cancer ConsortiumNational Cancer Institute (NCI)TerminatedKidney CancerUnited States
-
Ohio State University Comprehensive Cancer CenterBayer; NovartisCompletedMelanoma | Renal CancerUnited States
-
Genentech, Inc.CompletedMalignant MelanomaUnited States, Australia
-
Nantes University HospitalTerminated
-
M.D. Anderson Cancer CenterCelgeneCompletedAdvanced CancersUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)Completed
-
Italian Network for Tumor Biotherapy FoundationAstex Pharmaceuticals, Inc.Unknown
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Terminated
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)Completed
-
Astellas Pharma IncCompletedMelanomaUnited States, Canada
-
Italian Network for Tumor BiotherapyBristol-Myers SquibbCompletedMetastatic Malignant MelanomaItaly
-
National Cancer Institute (NCI)M.D. Anderson Cancer CenterWithdrawnSorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable MelanomaMelanoma | Recurrent Melanoma | Stage IV Melanoma | Stage III Melanoma